VOLTAREN EMULGEL BACK & MUSCLE PAIN DIN 02465035
Health Canada record
| Active ingredient(s) | DICLOFENAC DIETHYLAMINE 1.16 % |
|---|---|
| Dosage form | Gel |
| Route | Topical |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | M02AA15 DICLOFENAC |
| Original market date | 15-Mar-2018 |
| Current status date | 11-May-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Haleon Canada ULC — licence 100641, currently licensed, last inspection rating C (2025-10-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DICLOFENAC DIETHYLAMINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02555263 | PAIN RELIEF GEL EXTRA STRENGTH | TARO PHARMACEUTICALS INC | Gel | DICLOFENAC DIETHYLAMINE 2.32 % | Approved |
| 02554801 | VOLTAREN EMULGEL ACTIVE | HALEON CANADA ULC | Gel | DICLOFENAC DIETHYLAMINE 1.16 % | Marketed |
| 02393190 | VOLTAREN EMULGEL EXTRA STRENGTH | HALEON CANADA ULC | Gel | DICLOFENAC DIETHYLAMINE 2.32 % | Marketed |
| 02465043 | VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH | HALEON CANADA ULC | Gel | DICLOFENAC DIETHYLAMINE 2.32 % | Marketed |
| 02338580 | VOLTAREN EMULGEL JOINT PAIN REGULAR STRENGTH | HALEON CANADA ULC | Gel | DICLOFENAC DIETHYLAMINE 1.16 % | Marketed |
| 02290375 | VOLTAREN EMULGEL | HALEON CANADA ULC | Gel | DICLOFENAC DIETHYLAMINE 1.16 % | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 34772 | 2025-01-29 | New Drug Submission (NDS) | Change in manufacturer name |
| 21321 | 2018-09-14 | Supplement to a New Drug Submission (SNDS) | UPDATE DIRECTIONS OF USE AND CLEANING INSTRUCTIONS FOR THE NEW APPLICATOR CAP, AND EDITORIAL/MINOR CLARIFICATION CHANGES |
| 19453 | 2017-06-23 | New Drug Submission (NDS) |
International API supply for DICLOFENAC DIETHYLAMINE
1 active FDA Drug Master Files.
Request a quote for VOLTAREN EMULGEL BACK & MUSCLE PAIN